PTAB Invalidates Two Anacor KERYDIN® Patents, PTAB Litigation Blog
The PTAB found obvious all claims of U.S. Patent Nos. 7,582,621 and 7,767,657 in the three final written decisions issued on February 23, 2017 (IPR2015-01776, IPR2015-01780, and IPR2015-01785). This marks another victory for Coalition for Affordable Drugs (CFAD) — the petitioner in all three IPRs.
Read the full article at ptablitigationblog.com.